246 related articles for article (PubMed ID: 31013164)
1. BASELINE TSH LEVEL IS ASSOCIATED WITH RISK OF ANTI-PD-1-INDUCED THYROID DYSFUNCTION.
Pollack RM; Kagan M; Lotem M; Dresner-Pollak R
Endocr Pract; 2019 Aug; 25(8):824-829. PubMed ID: 31013164
[No Abstract] [Full Text] [Related]
2. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
[TBL] [Abstract][Full Text] [Related]
3. Changes in thyroid function and evolution of subclinical thyroid disease in older men.
Tan SY; Chubb SAP; Flicker L; Almeida OP; Golledge J; Hankey GJ; Yeap BB
Clin Endocrinol (Oxf); 2024 Feb; 100(2):170-180. PubMed ID: 38059618
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients.
Kotwal A; Kottschade L; Ryder M
Thyroid; 2020 Feb; 30(2):177-184. PubMed ID: 31813343
[No Abstract] [Full Text] [Related]
5. RAPID EVOLUTION OF THYROID DYSFUNCTION IN PATIENTS TREATED WITH NIVOLUMAB.
O'Malley G; Lee HJ; Parekh S; Galsky MD; Smith CB; Friedlander P; Yanagisawa RT; Gallagher EJ
Endocr Pract; 2017 Oct; 23(10):1223-1231. PubMed ID: 29045188
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation.
Baumgartner C; da Costa BR; Collet TH; Feller M; Floriani C; Bauer DC; Cappola AR; Heckbert SR; Ceresini G; Gussekloo J; den Elzen WPJ; Peeters RP; Luben R; Völzke H; Dörr M; Walsh JP; Bremner A; Iacoviello M; Macfarlane P; Heeringa J; Stott DJ; Westendorp RGJ; Khaw KT; Magnani JW; Aujesky D; Rodondi N;
Circulation; 2017 Nov; 136(22):2100-2116. PubMed ID: 29061566
[TBL] [Abstract][Full Text] [Related]
7. Assessment of thyroid function in two hundred patients with beta-thalassemia major.
Zervas A; Katopodi A; Protonotariou A; Livadas S; Karagiorga M; Politis C; Tolis G
Thyroid; 2002 Feb; 12(2):151-4. PubMed ID: 11916284
[TBL] [Abstract][Full Text] [Related]
8. Immune Checkpoint Inhibitor-induced Thyroid Dysfunction Is Associated with Higher Body Mass Index.
Pollack R; Ashash A; Cahn A; Rottenberg Y; Stern H; Dresner-Pollak R
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32668461
[TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms.
Delivanis DA; Gustafson MP; Bornschlegl S; Merten MM; Kottschade L; Withers S; Dietz AB; Ryder M
J Clin Endocrinol Metab; 2017 Aug; 102(8):2770-2780. PubMed ID: 28609832
[TBL] [Abstract][Full Text] [Related]
10. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score.
Strieder TG; Tijssen JG; Wenzel BE; Endert E; Wiersinga WM
Arch Intern Med; 2008 Aug; 168(15):1657-63. PubMed ID: 18695079
[TBL] [Abstract][Full Text] [Related]
11. [Clinical observation of thyroid-related adverse events induced by anti-PD-1 antibody SHR-1210 in patients with advanced solid tumor].
Qi L; Mo HN; Chen XL; Wang X; Wu DW; Lan B; Li Q; Wang XY; Xu JP; Yang Q; Xu BH; Huang J
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):772-775. PubMed ID: 30392342
[No Abstract] [Full Text] [Related]
12. Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study.
Wu L; Xu Y; Wang X; Cheng X; Zhang Y; Wang Y; Fan X; Zhao H; Liu H; Chai X; Zhang L; Wang M; Li N; Pan H; Lian X
Endocrine; 2023 Jul; 81(1):123-133. PubMed ID: 36867366
[TBL] [Abstract][Full Text] [Related]
13. Association between anti-thyroid peroxidase antibody and thyroid stimulating hormone: a cross-sectional study.
Shimizu Y; Matsuyama M; Noguchi Y; Takada M; Kawashiri SY; Fukui S; Nakamichi S; Nagata Y; Maeda T; Hayashida N
Sci Rep; 2023 Sep; 13(1):14358. PubMed ID: 37658108
[TBL] [Abstract][Full Text] [Related]
14. Screening of geriatric patients for thyroid dysfunction with thyrotropin-releasing-hormone test, sensitive thyrotropin and free thyroxine estimation.
Szabolcs I; Ploenes C; Bernard W; Herrmann J
Horm Metab Res; 1990 May; 22(5):298-302. PubMed ID: 2112111
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer Patients.
Lechner MG; Vyas CM; Hamnvik OR; Alexander EK; Larsen PR; Choueiri TK; Angell TE
Thyroid; 2018 Apr; 28(4):437-444. PubMed ID: 29652599
[TBL] [Abstract][Full Text] [Related]
16. Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.
Yamauchi I; Yasoda A; Matsumoto S; Sakamori Y; Kim YH; Nomura M; Otsuka A; Yamasaki T; Saito R; Kitamura M; Kitawaki T; Hishizawa M; Kawaguchi-Sakita N; Fujii T; Taura D; Sone M; Inagaki N
PLoS One; 2019; 14(5):e0216954. PubMed ID: 31086392
[TBL] [Abstract][Full Text] [Related]
17. Subclinical thyroid dysfunction and circulating thyroid hormones are not associated with bone turnover markers or incident hip fracture in older men.
Siru R; Alfonso H; Chubb SAP; Golledge J; Flicker L; Yeap BB
Clin Endocrinol (Oxf); 2018 Jul; 89(1):93-99. PubMed ID: 29655173
[TBL] [Abstract][Full Text] [Related]
18. Transient high thyroid stimulating hormone and hypothyroidism incidence during follow up of subclinical hypothyroidism.
Abu-Helalah M; Alshraideh HA; Al-Sarayreh SA; Al-Hader A
Endocr Regul; 2021 Dec; 55(4):204-214. PubMed ID: 34879182
[No Abstract] [Full Text] [Related]
19. Stability of thyroid function in older adults: the Birmingham Elderly Thyroid Study.
Roberts L; McCahon D; Johnson O; Haque MS; Parle J; Hobbs FR
Br J Gen Pract; 2018 Oct; 68(675):e718-e726. PubMed ID: 30154078
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint inhibitor-related thyroid dysfunction.
Iwama S; Kobayashi T; Yasuda Y; Arima H
Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101660. PubMed ID: 35501263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
